2018 NCI IMAT PI Meeting
19th Annual Innovative Molecular Analysis
Technologies Principal Investigators Meeting
November 28-30, 2018
Hilton Washington DC/Rockville, Rockville, MD
Welcome to the National Cancer Institute’s Innovative Molecular Analysis Technologies (IMAT) Principal Investigators Meeting to be held November 28‐30, 2018, at the Hilton Hotel & Executive Meeting Center in Rockville, MD.
Since 1998, the IMAT program (http://innovation.cancer.gov) has been a key component of NCI’s strategy for supporting innovative and emerging technologies for cancer research and clinical care and your involvement as a grantee is important. This annual meeting is organized to address two important aims of the IMAT program:
- Provide NCI program staff a chance to interact directly with PIs and receive an update on progress to date of supported research
- Present opportunities for interactions and exchanges of ideas among meeting participants, which is critical to sparking potentially transformative project collaborations, receiving critical feedback and guidance from the community, and fostering dissemination of the exciting technologies emerging from IMAT-supported researchers.
On behalf of the NCI program staff and everyone involved in the planning for this meeting, I thank you for your participation, your interest, and the important work you all do to assist in our collective mission against cancer. I look forward to an exciting and productive meeting.
Tony Dickherber, Ph.D.
Program Director, IMAT
Center for Strategic Scientific Initiatives
National Cancer Institute, National Institutes of Health
U.S. Department of Health & Human Services